IRIS
MEZZATESTA, Maria Lina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.309
EU - Europa 3.300
AS - Asia 2.458
SA - Sud America 493
AF - Africa 301
Continente sconosciuto - Info sul continente non disponibili 177
OC - Oceania 6
AN - Antartide 1
Totale 12.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.046
SG - Singapore 1.265
IT - Italia 1.147
RU - Federazione Russa 734
CN - Cina 663
BR - Brasile 394
IE - Irlanda 394
UA - Ucraina 370
CA - Canada 191
VN - Vietnam 187
CI - Costa d'Avorio 181
DE - Germania 169
FR - Francia 126
SE - Svezia 115
GB - Regno Unito 75
NG - Nigeria 54
IN - India 50
BD - Bangladesh 48
KR - Corea 40
AR - Argentina 36
MX - Messico 33
JP - Giappone 29
TR - Turchia 27
PL - Polonia 25
IQ - Iraq 24
HK - Hong Kong 22
NL - Olanda 22
ZA - Sudafrica 19
EC - Ecuador 18
ES - Italia 16
FI - Finlandia 15
PK - Pakistan 15
BE - Belgio 14
SN - Senegal 14
UZ - Uzbekistan 14
AT - Austria 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
CO - Colombia 9
JM - Giamaica 9
JO - Giordania 9
NO - Norvegia 9
VE - Venezuela 9
EG - Egitto 8
LB - Libano 8
LT - Lituania 8
PY - Paraguay 8
CL - Cile 7
CR - Costa Rica 7
HN - Honduras 7
IR - Iran 7
RO - Romania 7
AU - Australia 5
BO - Bolivia 5
ID - Indonesia 5
KE - Kenya 5
KZ - Kazakistan 5
SA - Arabia Saudita 5
DZ - Algeria 4
HR - Croazia 4
NP - Nepal 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
BJ - Benin 3
CZ - Repubblica Ceca 3
EU - Europa 3
HU - Ungheria 3
MA - Marocco 3
PE - Perù 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
MT - Malta 2
PA - Panama 2
PH - Filippine 2
QA - Qatar 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BM - Bermuda 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
KN - Saint Kitts e Nevis 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 11.858
Salva come PNG Salva come JPEG
Città #
Singapore 729
Santa Clara 712
Dallas 688
San Jose 433
Jacksonville 411
Dublin 393
Chandler 348
Moscow 289
Ashburn 252
Messina 209
Catania 203
Los Angeles 193
Abidjan 181
Boardman 179
Chicago 122
Beijing 121
Nanjing 111
Council Bluffs 110
Toronto 108
Andover 107
Lawrence 107
Cambridge 105
Bremen 100
Lauterbourg 94
Des Moines 66
Hefei 65
Ho Chi Minh City 62
San Mateo 54
Taormina 52
São Paulo 48
Civitanova Marche 46
Belpasso 44
Wilmington 44
Reggio Calabria 43
New York 41
Seoul 40
Palermo 39
Hebei 33
Montreal 32
Shenyang 32
Nanchang 31
Jiaxing 29
Ottawa 29
Tokyo 29
Grafing 28
Hanoi 28
Rome 28
Buffalo 27
Lagos 27
Acireale 21
Milan 20
Tianjin 20
Changsha 19
Phoenix 19
Abuja 18
Mendicino 18
Warsaw 18
London 17
Brooklyn 16
Chennai 16
Columbus 16
Frankfurt am Main 16
Hong Kong 16
Saint Petersburg 16
Atlanta 15
Denver 15
Mascalucia 15
Orem 15
Bologna 14
Brussels 14
Dakar 14
Boston 13
Amsterdam 12
Brolo 12
Munich 12
Rio de Janeiro 12
Syracuse 12
The Dalles 12
Ankara 11
Falls Church 11
Haiphong 11
Houston 11
Mexico City 11
Augusta 10
Johannesburg 10
San Francisco 10
Brasília 9
Kunming 9
Port Harcourt 9
Tromsø 9
Amman 8
Baghdad 8
Belo Horizonte 8
Stockholm 8
Washington 8
Bronte 7
Charlotte 7
Dhaka 7
Dong Ket 7
Hangzhou 7
Totale 7.951
Salva come PNG Salva come JPEG
Nome #
Attività antibatterica di netilmicina e netilmicina/desametasone, in paragone con altri antibiotici, verso Gram-positivi e Gram-negativi isolati da infezioni oculari. 197
A multicenter study on central venous catheter-associated infections in Italy 187
Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy 176
Mutation- and Transcription-Driven Omic Burden of Daptomycin/Dalbavancin-R and Glycopeptide-RS Fitness Costs in High-Risk MRSA: A Nexus in Antimicrobial Resistance Mechanisms—Genome Proneness—Compensatory Adaptations 175
Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy 171
Fitness Burden for the Stepwise Acquisition of First- and Second-Line Antimicrobial Reduced-Susceptibility in High-Risk ESKAPE MRSA Superbugs 166
Overview of the Clinical and Molecular Features of Legionella Pneumophila: Focus on Novel Surveillance and Diagnostic Strategies 155
Cefditoren versus community acquired respiratory pathogens: time kill studies 148
Aspetti Microbiologici e legislativi delle piscine:valutazione dell’azione batterica di due disinfettanti a base di cloro, comunemente utilizzati in piscina 148
Attività antibatterica in vitro dell’associazione thrimethoprim/sulfadiazina 148
Activity of Tigecycline against well characterized multi-resistant Gram-positive strains 147
Cell-free supernatant of Lactobacillus gasseri 1A-TV shows a promising activity to eradicate carbapenem-resistant Klebsiella pneumoniae colonization 147
Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis 145
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions 144
Attività in vitro di tigeciclina e altri antibiotici verso Acinetobacter baumannii isolati da infezioni gravi in Italia 144
Antipneumococcal activity of telithromycin in comparison with other drugs in relation to the presence of different resistance genes 144
Activity of telithromycin against multi-drug resistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance determinants 143
Antimicrobial and Antibiofilm Activity of a Lactobacillus reuteri SGL01, Vitamin C and Acerola Probiotic Formulation Against Streptococcus mutans DSM20523 139
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method. 136
Antibacterial activity of PZ-601 against well-characterized and recent clinical isolates of methicillin-resistant Staphylococcus aureus 134
Gain-in omic signatures of colistin-resistant Acinetobacter baumannii undergoing colistin therapy. 132
Extensively drug-resistant ArmA-producing Acinetobacter baumannii in an Italian intensive care unit 132
Attività Battericida di Cefditoren nei Confronti di Patogeni Respiratori Acquisiti in Comunità 132
Infections with VIM-1 metallo beta-lactamase producing Enterobacter cloacae and their correlation with clinical outcome 131
In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci. 128
Biofilm production and correlation with agr-allele distribution in medical-devices associated with Staphylococcus aureus 128
Antibacterial activity of Netilmicin and Netilmicin/Dexamethasone fixed combination against the most common ocular isolates 127
Detection of the IncX3 plasmid carrying blaKPC-3in a Serratia marcescens strain isolated from a kidney-liver transplanted patient 127
Gold standard susceptibility testing of fosfomycin in Staphylococcus aureus and Enterobacterales using a new agar dilution panel® 127
Attività in vitro di piperacillina/tazobactam in paragone ad altri antibiotici nei confronti di germi multiresistenti 123
Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy 123
In vitro evidence of the synergistic interaction of ceftopibrole and other antibiotics against multidrug-resistant Gram-negative isolates 123
Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury: A case report. 122
Bactericidal activity of doripenem against carbapenem-resistant Acinetobacter baumanni 121
Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence 120
Infections of cardiovascular implantable electronic devices: 14 years of experience in an Italian hospital 119
Attività antibatterica in vitro di dactimicina (ST 900), nuovo antibiotico aminoglucosidico nei confronti di bacilli Gram negativi 119
Study on the in-vitro activity of LY333328 against Gram-positive cocci 118
Bactericidal activity of ertapenem against major intra-abdominal pathogens 118
Attività di Ofloxacin nei confronti di batteri responsabili di infezioni oculari esterne 115
Extended-spectrum beta-lactamase-producing and carbapenemase- producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin 115
Attività antibatterica di cefditoren e altri antibiotici verso S.pneumoniae ed H.influenzae isolati da infezioni respiratorie comunitarie in Italia 113
In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy 112
Flora batterica e micotica nel condotto uditivo esterno 110
In vitro activity of Sulbactam/ampicillin and other antibiotics against clinical isolates of Haemophilus species and Branhamella catarrhalis 108
In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae 108
In vitro Activity of Tigecycline and Comparators against Carbapenem-Susceptible and Resistant Acinetobacter baumannii Isolated from Severe Infections in Italy 107
Attività antibatterica in vitro di Linezolid nei confronti di Stafilococchi ed Enterococchi isolati in Italia 106
Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. 104
Bloodstream Infections Due to Carbapenemase-Producing Escherichia coli: A Comprehensive Review 103
Comparative In-Vitro Activity of Piperacillin and Piperacillin Plus Tazobactam Towards Beta-Lactamase Producing Clinical Isolates 102
Spread of Enterobacteriaceae carrying the PER-1 extended-spectrum β-lactamase gene as a chromosomal insert: a report from Italy 99
Molecular Epidemiology of Enterococci with High-Level Resistance to Aminoglycosides 98
Preliminary results on the antibacterial activity of sagamicin towards microrganisms responsible for ocular pathology 98
Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants 98
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy 97
In vitro activity of fosfomycin trometamol and other oral antibiotics against multi-drug-resistant uropathogens 97
Emergence of an extensively drug-resistant ArmA- and KPC-2-producing ST101 Klebsiella pneumoniae clone in Italy. 96
Spettro di resistenza agli antibiotici in patogeni isolati da reparti di terapia intensiva: Studio Policentrico Retrospettivo Italiano 94
Correlazione tra il background genetico e le varianti di SCCmec dei maggiori cloni di Staphylococcus aureus meticillino-resistenti (MRSA), circolanti in Italia 94
SNPs in genes involved in lipid a phosphoethanolamine transferase over-expression and proline biosynthesis are associated with colistin resistance in Acinetobacter baumannii 93
Antibacterial and cytotoxic effects of chlorhexidine combined with sodium DNA on oral microorganisms: an in vitro study usingDictyostelium discoideum 92
Bactericidal activity of doripenem against carbapenem-resistant acinetobacter baumannii 92
Clonal diffusion of colistin resistant OXA-23 Acinetobacter baumannii from 4 different hospitals: is really one clone only? 90
Circolazione epidemiologica di beta-lattamasi: superamento delle resistenze da parte della associazione amoxicillina/acido clavulanico 90
ica A and ica D co-expression determines biofilm production in Staphylococcus epidermidis and ica-operon distribution is independent of the source of isolation 89
In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates 89
Identification and Characterization of a New Metallo-_-Lactamase, IND-5, from a Clinical Isolate of Chryseobacterium indologenes 88
Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs 88
In vitro activity of tigecycline and comparators against Acinetobacter baumannii isolated from severe infections in Italy 87
Incidenza ed antibiotico resistenza delle diverse specie di stafilococco in ambienti nosocomiali della Sicilia Orientale 86
Observations on the tollerance and the paradoxical effect in Enterococci 84
Comparative activity of linezolid against Staphylococci and Enterococci isolated in Italy 84
In vivo multiclonal transfer of blaKPC-3 from Klebsiella pneumoniae to Escherichia coli in surgery patients 84
High-level resistance to aminoglycosides in enterococci: incidence and alternative active antibiotic combinations in vitro 84
Tigecycline in vitro activity against clinically-relevant multi-resistant Gram-positive and Gram-negative pathogens 83
Role of empirical and definitive therapy in hospitalised patients with bloodstream infections caused by extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae: a prospective cohort observational study. 83
Three major A.baumannii clones account for all carbapenem-resistant strains in Italy 83
Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae. 83
Outbreak of KPC-3-producing, and colistin resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. 82
Principali cloni di A.baumannii carbapenemi-resistenti circolanti in Italia 82
PZ-601 antibacterial activity against well-characterised and fresh Enterobacteriaceae isolates 82
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae. 82
Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit 82
Preliminary results on the antbacterial activity of sagamicin towards pathology 80
In vitro evaluation of daptomycin in combination with other drugs against difficult to treat staphylococci and enterococci 79
Dall’emergenza alla diagnosi 78
Risk of treatment failure of A.baumanni infections in solid organ transplantion: discrepancy in interpretation of sensitivity values of colistin in routine microbiological diagnostics. 78
Correlation between icaAD expression and biofilm production in S.epidermidis 77
Polimorfismi genomici di Stafilococchi coagulasi-negativi isolati da catetere 77
Preliminary results on the antibacterial and killing activity of lomefloxacin 77
Prolonged bacteraemia caused by VIM-1 metallo-b-lactamase-producing Proteus mirabilis: first report from Italy 77
Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate. 75
Valutazione dell’azione battericida di due disinfettanti a base di cloro, comunemente usati in piscina 75
Diffusione di erm(B), mef(A) e tet(M) mediata da elementi mobili: localizzazione e variabilità genomica in Streptococchi orali 73
ICA A and ICA D co-expression determines biofilm production in S.epidermidis and ICA-operon distribution in indipendent of the source of isolation 73
Class I integron-borne blaVIM-1 carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia 72
Studies on Lincosamide Antibiotic Resistance in Methicillin-Susceptible and resistant Staphylococci 72
Studio della Eventuale Interferenza di Cefatrizina sulla Flora Batterica Intestinale e del Cavo Orale: Breve Nota 71
Risultati preliminari su uno studio in doppio cieco con ofloxacin 0,3% e tobramicina 0,3% in pazienti con infezioni oculari esterne 71
Totale 10.905
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022589 0 0 0 17 124 12 112 20 91 3 11 199
2022/20231.240 115 51 16 176 107 219 6 171 303 11 39 26
2023/2024631 34 101 18 50 19 157 9 15 1 11 94 122
2024/20252.178 14 288 111 104 528 233 84 75 161 206 169 205
2025/20264.974 319 360 755 311 725 872 587 183 202 316 227 117
2026/2027670 141 236 136 157 0 0 0 0 0 0 0 0
Totale 12.045